#PharmaNews #HealthcareInnovation #PharmaStrategy #IndianPharma #PharmaUpdates #Harshal #PharmawithHJ #HJ To view or add a comment, sign in The Weight Loss Drug That's Making GLP-1s Look Like Yesterday's News While everyone's talking about Ozempic and Wegovy, there's a compound quietly outperforming them in clinical trials that most doctors haven't even heard of
Luengo E, Alvarez I, Raso J
SunHSaeediPKarurangaSPinkepankMOgurtsovaKDuncanBBet al
A part of Watch Medier Director, Drug Safety Operations Global Clinical Lead, Clinical Development, Migraine & Pain Senior Safety Manager Pharmacokineticist, PK/PD Modelling & Simulation Medical Writer responsible for Clinical Disclosure Clinical Supply Manager You need to be a subscriber to read the rest of the article
Key Points Semaglutide causes diarrhea through multiple mechanisms slowing stomach emptying while speeding up colon activity and affecting nutrient absorption Higher semaglutide doses used for weight loss (Wegovy) cause more GI issues than diabetes doses (Ozempic) Most people see improvement over time as their body adapts to the medication The diarrhea doesn't mean the drug is "working better" Starting semaglutide (Ozempic or Wegovy) can be an exciting development in your diabetes or weight loss journey
Honestly, though, for most tendon and ligament-focused studies, the Sub-Q method is perfectly sufficient and carries a lower risk profile
